Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2026-02-24 @ 10:55 AM
Study NCT ID:
NCT00086658
Status:
COMPLETED
Last Update Posted:
2020-05-05
First Post:
2004-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
100185
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None